Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | THRB | P10828 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
| ▸ | BLM | P54132 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 3/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.38 |
| ▸ | NPC1 | O15118 | 2/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | ANPEP | P15144 | 3/20 | 0.37 |
| ▸ | RNPEP | Q9H4A4 | 3/20 | 0.37 |
| ▸ | DNPEP | Q9ULA0 | 2/20 | 0.37 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.36 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.36 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.36 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | CA1 | P00915 | 1/20 | 0.36 |
| ▸ | MME | P08473 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14930545 | 1.00 | ALDH1A1 (0.46) | ALDH1A1THRBTSHRHSD17B10BLM | |
| SCHEMBL28791290 | 0.86 | BLM (0.45) | ALDH1A1THRBTSHRHSD17B10BLM | |
| SCHEMBL11932566 | 0.86 | BLM (0.45) | ALDH1A1THRBTSHRHSD17B10BLM | |
| SCHEMBL20677353 | 0.85 | TSHR (0.40) | ALDH1A1THRBTSHRHSD17B10RNPEP | |
| SCHEMBL14037307 | 0.85 | TSHR (0.40) | ALDH1A1THRBTSHRHSD17B10RNPEP | |
| SCHEMBL11762930 | 0.83 | BLM (0.42) | ALDH1A1THRBTSHRHSD17B10BLM | |
| SCHEMBL7935227 | 0.83 | BLM (0.42) | ALDH1A1THRBTSHRHSD17B10BLM | |
| SCHEMBL19930273 | 0.81 | RAB9A (0.39) | ALDH1A1THRBTSHRHSD17B10RAB9A | |
| SCHEMBL23748061 | 0.80 | GABRR1 (0.40) | ALDH1A1THRBTSHRHSD17B10BLM | |
| SCHEMBL15694717 | 0.80 | ACE2 (0.39) | ALDH1A1THRBTSHRHSD17B10BLM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117440838-A | Compositions comprising crosslinked hyaluronic acid and methods of use thereof | 哈鲁拉公司 | 2024-01-23 | — | — | CN | disclosed |
| CN-114644651-A | Process for producing aryloxyphosphorylated amino acid ester compound | 中国人民解放军军事科学院军事医学研究院 | 2022-06-21 | — | — | CN | disclosed |
| US-10640528-B2 | Macrolides with modified desosamine sugars and uses thereof | PRESIDENT AND FELLOWS OF HAVARD COLLEGE (US) | 2020-05-05 | — | — | US | disclosed |
| US-20180066008-A1 | MACROLIDES WITH MODIFIED DESOSAMINE SUGARS AND USES THEREOF | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2018-03-08 | — | — | US | disclosed |
| US-20180066008-A1 | MACROLIDES WITH MODIFIED DESOSAMINE SUGARS AND USES THEREOF | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2018-03-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180066008-A1 | MACROLIDES WITH MODIFIED DESOSAMINE SUGARS AND USES THEREOF | FUT6, MGAM, B3GNT2 | ALDH1A1 3204/4885THRB 2633/4885TSHR 3186/4885 |
| US-10640528-B2 | Macrolides with modified desosamine sugars and uses thereof | FUT6, MGAM, B3GNT2 | ALDH1A1 3204/4885THRB 2633/4885TSHR 3186/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.